10-Q: Stepan Company Reports First Quarter 2024 Results Amidst Pricing Pressures and Operational Challenges

Stepan Company's first quarter 2024 net income decreased to $13.9 million, or $0.61 per diluted share, compared to $16.1 million, or $0.70 per diluted share, in the same period last year, primarily due to lower average selling prices.

Summary

• Stepan Company's net sales for the first quarter of 2024 were $551.4 million, a decrease of 15% compared to $651.4 million in the first quarter of 2023.
• The decrease in net sales was primarily due to lower average selling prices, which negatively impacted sales by $115.5 million, while sales volume increased by 1%, contributing $3.7 million.
• Foreign currency translation had a positive impact of $11.8 million on net sales.
• Net income for the quarter was $13.9 million, or $0.61 per diluted share, compared to $16.1 million, or $0.70 per diluted share, in the first quarter of 2023.
• Adjusted net income was $14.7 million, or $0.64 per diluted share, compared to $16.4 million, or $0.71 per diluted share, in the first quarter of 2023.
• EBITDA was $50.2 million in the first quarter of 2024, compared to $48.3 million in the first quarter of 2023.
• Adjusted EBITDA was $51.2 million, a 5% increase compared to $48.7 million in the first quarter of 2023.
• The company's effective tax rate increased to 28.6% in the first quarter of 2024 from 18.9% in the first quarter of 2023, due to the election of Bonus Depreciation for the new alkoxylation facility.
• Operating income decreased by 4% to $20.2 million, compared to $21.1 million in the first quarter of 2023.
• The company estimates capital expenditures for 2024 to be between $120 million and $140 million.

Sentiment

Score: 5

Explanation: The document presents mixed results with decreased net sales and net income but increased adjusted EBITDA. The company is facing pricing pressures and operational challenges, but management is taking steps to improve performance. The outlook is cautiously optimistic.

Positives

• Adjusted EBITDA increased by 5% year-over-year.
• Sales volume increased by 1% overall.
• Specialty Products sales volume increased by 11%.
• Operating expenses decreased by 5% year-over-year.
• The company is focused on delivering $50 million in pre-tax savings from its cost reduction program.
• Foreign currency translation had a positive impact on net sales by $11.8 million.

Negatives

• Net sales decreased by 15% year-over-year.
• Net income decreased to $13.9 million, or $0.61 per diluted share.
• Lower average selling prices negatively impacted net sales by $115.5 million.
• The effective tax rate increased to 28.6%.
• Surfactant operating income decreased by $1.0 million.
• Polymer operating income decreased by $1.6 million.
• There were operational interruptions at the Millsdale, Illinois plant.

Risks

• The company faces risks related to accidents, unplanned production shutdowns, and disruptions in manufacturing facilities.
• Reduced demand for products due to customer reformulations or new technologies is a risk.
• The company's ability to successfully develop or introduce new products is a risk.
• Compliance with environmental, health and safety, product registration, and anti-corruption laws poses a risk.
• The company faces risks related to global competition and its ability to compete.
• Volatility of raw material, natural gas, and electricity costs, as well as supply disruptions, are risks.
• Disruptions in transportation or significant changes in transportation costs are risks.
• Downturns in certain industries and general economic downturns pose risks.
• International business risks, including fluctuations in currency exchange rates, legal restrictions, and taxes, are risks.
• Unfavorable resolution of litigation against the company is a risk.
• The company's ability to keep and protect its intellectual property rights is a risk.
• Potentially adverse tax consequences due to the international scope of operations are a risk.
• Downgrades to the company's credit ratings or disruptions to its ability to access capital markets are risks.
• Conflicts, military actions, terrorist attacks, and general instability are risks.
• Cost overruns, delays, and miscalculations in capacity needs with respect to expansion or other capital projects are risks.
• Interruption of, damage to, or compromise of the company's IT systems is a risk.
• The company's ability to retain executive management and other key personnel is a risk.
• The company's ability to operate within the limitations of debt covenants is a risk.

Future Outlook

Management believes sales volumes will continue to gradually improve due to ongoing recovery in Rigid Polyols demand and growth in Surfactant sales volumes, inclusive of the expected recovery of the agricultural business in the second half of the year. Management believes free cash flow should continue to improve versus prior year as the Company finishes construction on its Pasadena investment and benefits from higher anticipated agricultural sales volumes in the second half of the year. Management believes continued gradual sales volume growth, improved operational performance and its continued focus on cost reduction should position the Company to deliver full year adjusted EBITDA growth and positive free cash flow in 2024.

Management Comments

• Management remains focused on delivering $50.0 million in pre-tax savings from its previously shared cost reduction program.
• Management believes free cash flow should continue to improve versus prior year.
• Management remains confident in the Company's long-term growth and innovation initiatives.

Industry Context

The chemical industry is experiencing pricing pressures due to lower raw material costs and increased competition, which is reflected in Stepan's results. The company's focus on cost reduction and operational improvements aligns with industry trends to maintain profitability in a challenging market. The recovery in rigid polyols demand and the expected rebound in the agricultural sector are positive signs for the company's future performance.

Comparison to Industry Standards

• Stepan's decrease in net sales and net income is consistent with the challenges faced by other chemical companies in the first quarter of 2024 due to lower raw material costs and competitive pricing pressures.
• Companies like Dow and BASF have also reported similar impacts on their financial results, indicating a broader industry trend.
• Stepan's focus on cost reduction and operational improvements is a common strategy among chemical companies to mitigate the impact of these challenges.
• The company's adjusted EBITDA growth of 5% is a positive sign, suggesting that its cost-cutting measures are having some effect.
• Compared to companies like Ecolab, which focuses on cleaning and hygiene solutions, Stepan's performance is more directly tied to the fluctuations in raw material costs and demand for industrial chemicals.
• The company's capital expenditure plans for the new alkoxylation plant in Pasadena, Texas, are similar to other chemical companies investing in capacity expansion to meet future demand.

Legal Proceedings

• The company is involved in various legal proceedings, primarily related to environmental matters.
• A consent decree was entered for the Maywood site, requiring the company to take certain actions and pay past costs.
• The company received a Notice of Violation from the USEPA for the Millsdale facility, alleging violations of air regulations.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and sales, but encouraged by the adjusted EBITDA growth and cost reduction efforts.
• Employees may be affected by the cost reduction program and operational changes.
• Customers may benefit from lower prices due to the pass-through of lower raw material costs.
• Suppliers may be impacted by changes in demand and production volumes.
• Creditors may be monitoring the company's debt levels and compliance with debt covenants.

Next Steps

• The company will continue to focus on delivering $50 million in pre-tax savings from its cost reduction program.
• The company will complete construction of its new alkoxylation plant in Pasadena, Texas.
• The company anticipates improved agricultural sales volumes in the second half of the year.

Key Dates

Keywords

Surfactants, Polymers, Specialty Products, Net Sales, EBITDA, Operating Income, Financial Results, Chemicals, Manufacturing, Raw Materials